| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |